Do bigger brains have better memories?

Hint: researchers don't think so.

For many years, scientists believed that bigger brains (or more specifically, a bigger hippocampus) were associated with higher aptitude and that smaller brains were then necessarily a sign of lower aptitude, or even of cognitive decline when caused by a neurological disease like Alzheimer’s. And even though some studies suggested that there might not be such a simple relationship, scientists were uncertain of what an alternative model might be. Until now. 

A study published in the journal Cerebral Cortex in December 2019 has, for the first time, demonstrated that it’s not necessarily the size of the hippocampus that matters but rather how well it’s connected to the brain’s internal circuitry, through intact limbic white matter. In other words, the study suggests that cognitive decline could stem from a poor circuitry connection rather than a smaller hippocampus alone.

The Puzzle Pieces of Memory

The hippocampus is a small, seahorse-like piece of the brain, buried deep within the temporal lobe — the epicenter of all things learning and memory. Yet, despite its important role, the hippocampus’s malleable and vulnerable exterior leaves it exposed to damage, including neurological and psychiatric disorders. In particular, the hippocampus has been observed to shrink in the brains of patients suffering from Alzheimer’s.

Limbic white matter, on the other hand, is a little more difficult to point to directly. While a C-shaped bundle of nerves (called the fornix) is primarily responsible for transmitting signals to and from the hippocampus, the limbic system as a whole is a complex microstructure, which manages emotions, memories, and our senses.

Unravelling the Mystery

To study how these two pieces of the brain work together to affect memory and cognition, the team of researchers at Michigan State University looked at the brain scans of 337 older adults, roughly two-thirds male and one-third female, with an average age of 69-years-old. 

To determine their level of working memory, the subjects completed five sessions of memory recall tests, during which they were read the same list of 15 nouns and asked to write down as many as they could remember after each round. 

The research team then analyzed two different types of MRI scans — one of their hippocampus and one of their limbic white matter. The team observed that participants with both comparatively larger hippocampuses and uniform limbic white matter had stronger memory recall than subjects with either smaller hippocampuses or less uniform limbic white matter. Uniform, in this case, refers to the alignment of the limbic white matter’s microstructure: white matter aligned in one direction (like the grain of a wood plank) appeared to better facilitate memory than white matter microstructure aligned in many different directions. This suggests that hippocampus size alone is not a sign of mental aptitude and that a shrinking hippocampus isn’t necessarily an accurate biomarker for disease or age related cognitive decline. For example, a patient suffering from Alzheimer’s could demonstrate signs of cognitive decline while still having a larger hippocampus if their limbic white matter microstructure was not uniformly aligned. According to the study’s authors, these findings could lead to earlier diagnosis of age-related memory disorders for adults whose brain scans show a larger hippocampus. Because of their larger hippocampus, these adults are at-risk of having their “cognitive decline overlooked or mischaracterized if physicians do not also consider their white matter connectivity.”

Gray Areas and Next Steps

While the study authors consider these results an “encouraging” step toward better understanding the brain’s mysteries, they also write in the paper that they are far from foolproof. For example, the current study relied on limited timeframe and curated participant group (i.e. unimpaired and of similar ages). To address these lingering questions going forward the team suggests conducting a study over a longer period of time with a more diverse group of participants to see how these relationships change over time.

The case for viewing depression as a consciousness disorder
A new hypothesis explains depression as an altered state of consciousness, which could help researchers make an objective diagnostic test.
First ever therapy for rare genetic disorder now approved
The FDA has approved the first drug for Rett syndrome, a genetic neurodevelopmental disorder, which disproportionately affects women and girls.
Psychedelics open a new window on the mechanisms of perception
Some neuroscientists think psychedelics and the hallucinations they induce could help reveal how we generate our perceptions of the world.
Here’s how your sleep affects your immune system
Researchers found that patients who slept less than six hours a night were 27% more likely to have an infection.
Scientists inject stem cells into the brain of Parkinson’s patient
A new stem cell therapy for Parkinson’s disease has just been administered to the brain of a person for the first time.
Up Next
robotic tackling dummy
Subscribe to Freethink for more great stories